Objective #1: Understanding the trend in Health Care Economics driving the change from Medicare to Medicare Advantage

Objective #2: Recognizing the importance of Primary Care being the core to the success of future models of care.

Objective #3: Recognizing the importance of moving towards risk-based contracts. Payment for Quality - managing "populations."

Virginia Irwin-Scott, DO, MBA, CPE, FASN, FACOI, National Director of Kidney Care

Session details coming soon.

Sheila M. Mints, Esq., Chair of Capehart Scatchard’s Health Care Group

Session details coming soon.

Camille S. Bonta, MHS (she/her/hers), Principal, Summit Health Care Consulting

1.  Review previous discussion about Physician/Provider Burnout

2.  Discuss Selgman's PERMA Framework as a tool for positive workplace functioning and wellbeing

3.  Discuss Donaldson's PERMA+4 Framework as it relates to positive workplace functioning and wellbeing

Jeffrey M. Krepps, PhD, Associate Professor of Behavioral Health, Campbell University, School of Osteopathic Medicine

Julie Sterbank, DO, FACOI, Associate Professor, Internal Medicine & Pediatrics; Adult and Pediatric, Allergy & Immunology, Case Western University/MetroHealth Medical Center

Angela J. De Hamer, DO, FACOI, Physician/Assistant Professor, MercyOne/DMU

Objective #1: To highlight the significant need for Menopause education

Objective #2: Highlight the prevalence of Anxiety and depression menopause

Objective #3: Point out disparities in menopausal mental health care

Machelle M. Seibel, MD, Founding Editor, The Hot Years Magazine Formerly, Assoc Professor Ob/Gyn Beth Israel Hospital, Harvard Medical School Boston, MA

Verna Brooks McKenzie, MB, BS, DGO, DM (O&G), NCMP, Online Menopause Consultation Service Police Athletic League (PAL) Adjunct-Professor, Touro University Medical Imaging Harlem Hospital

Karen Giblin, MS, Founder and President - Red Hot Mamas North America Inc.

Objective #1: Identify the latest concepts in the pathogenesis and diagnosis of COPD and their relationship to previous understandings of the condition

Objective #2: Understand new treatment algorithms and their underlying evidence

Objective #3: Describe future opportunities for COPD research (including prevention and diagnostics)

Michael W. Hess, MPH, RRT, RPFT, Senior Director of Public Outreach and Education COPD Foundation

Objective #1: Discuss current epidemiology of pulmonary embolism in the United States.

Objective #2: Review current concepts of pulmonary embolism care.

Objective #3: Discuss typical post hospital follow up for patients with pulmonary embolism.

Robert Schilz, DO, PhD, Associate Professor of Medicine Case University, Cleveland, OH

1. Discuss the Delayed Sequence Intubation approach to airway management in EMS.

2. Explain the role out process for DSI to an EMS Agency.

3. Identify limitations to the implementation of the DSI approach.

4. Recognize the pitfalls to simulation in EMS.

Samuel Rodriguez, MD, Teaching Faculty, Department of EMS Director of Clinical Education Harris County Emergency Corps

Objective #1: DISCUSS WHEN AND HOW TO FEED TO IMPACT SEPSIS?

Objective #2: DISCUSS HOW MUCH NUTRITION IS ENOUGH?

Objective #3: DISCUSS HOW PREMORBID MEDICATIONS ALTER SEPSIS?

Patrick C. Cullinan, DO, FACOI, Neurosurgical Intensivist Specialist, Department of Neurosurgery, University of Texas Health Science Center

Objective #1: Discuss the concept of the Arrest Cycle.

Objective #2: Explain the importance of an algorithmic approach to cardiac arrest

Objective #3: Identify the principle of a clinical debrief post-event

Samuel Rodriguez, MD, Teaching Faculty, Department of EMS Director of Clinical Education Harris County Emergency Corps

Objective #1: To demonstrate the harms that can, and do, occur as a result of tests and/or procedures that could have been avoided

Objective #2: To demonstrate the wastefulness of extensive patient testing when ordered inappropriately

Objective #3: To help make our Osteopathic Internists more thoughtful, more compassionate, more knowledgable, and overall uniquely more capable clinicians than their allopathic counterparts

Mark D. Baldwin, DO, FACOI, FASN (he/him/his), Professor and Chair, Department of Internal Medicine, Pacific Northwest University of Health Sciences

Gerald W. Blackburn, DO, MACOI, Clinical Professor of Medicine, Michigan State University, College of Osteopathic Medicine

Patrick C. Cullinan, DO, FACOI, Neurosurgical Intensivist Specialist, Department of Neurosurgery, University of Texas Health Science Center

Bryan L. Martin, DO, MACOI (he/him/his), Emeritus Professor of Medicine, The Ohio State University

Lauren Mazzucco, DO, FACOI, Medical Director, Hospice & Palliative Medicine Hampton Veterans Affairs Medical Center, Hampton VA

Objective #1: Review current classification system for pulmonary hypertension (PH) with an emphasis on rare types which require specialized referral.

Objective #2: Review key elements of workup which often separate pulmonary arterial hypertension from other types of PH.

Objective #3: Briefly review modern approaches to therapy and risk stratification of patients with pulmonary arterial hypertension (PAH).

Robert Schilz, DO, PhD, Associate Professor of Medicine Case University, Cleveland, OH

Objective #1: Discuss the basics of a healthy life, factors that motivate us to exercise.

Objective #2: Discuss how to stick to your healthy habits, how to make it a lifestyle.

Objective #3: Discuss mindfulness, and relaxation as a crucial part of your fitness/wellness journey - it's not always about powering up but powering down and recovering too.

Joanne Kaiser-Smith, DO, FACOI (President), Associate Dean

Damon L. Baker, DO, FACOI (Program Chair), Professor and Chair

Tony Horton, Founder, Power Life by Tony Horton

Objective #1: Define microbiome;

Objective #2: Understand pathophysiology of dysbiosis;

Objective #3: Understand the potential manifestations of untreated dysbiosis

Charlene A. LePane, DO, MBA, MSPH, FACOI, FACG, FASGE (she/her/hers), Chief Medical Information Officer/Gastroenterologist, AdventHealth

Objective #1: To review and discuss latest guidelines regarding COVID and seasonal influenza vaccinations

Objective #2: To review updated vaccination guidelines for routine adult vaccines

Objective #3: To discuss additional vaccine recommendations for certain higher risk travel abroad

Mia A. Taormina, DO, FACOI, Chair, Department of Infectious Disease, Duly Health and Care

Objective #1: Identify patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis and initiate therapies that can reduce risk of serious liver damage.

Objective #2: Describe treatment options for managing patients with metabolic-associated fatty liver disease.

Objective #3: Summarize lifestyle and dietary interventions that can be key factors associated with successfully reducing risk in patients with NAFLD

Robert P. Aran, DO, Chief Fellow, Oklahoma State University (Tulsa)

NON-CME Sponsored by AstraZeneca. Session details coming soon.

Miguel K. Lob, PharmD

Objective #1: Discuss gout risk factors and diagnosis.

Objective #2: Understand gout management strategies individualized to the person: A three pronged approach: urate lowering therapy, anti-inflammatories and risk mitigation.

Objective #3: Recognize that gout is a chronic condition that can lead to extra-articular manifestations with long-term complications/co-morbidities.

Priyanka A. Murali, DO, FACOI, Rheumatology Site Director, C.W. Bill Young VA Medical Center

Objective #1: Discuss ongoing research in the field of spondyloarthropathies and the microbiome.

Objective #2: Describe unique findings of the gut microbiome in those with diagnosed spondyloarthropathies.

Objective #3: Design a care plan that incorporates an integrative approach to the treatment of those with spondyloarthropathies.

Mary E. Hinojos Mamut, DO, Rheumatology Board Certified (AOBIM & ABIM), Mercy Clinic

Objective #1: To understand the fundamentals of inflammation and its impact on human health: This objective aims to provide participants with a comprehensive understanding of inflammation, its causes, and its effects on various body systems. The lecture will cover the mechanisms of inflammation and the role of chronic inflammation in the development of diseases.

Objective #2: To explore the concept of anti-inflammatory diets: This objective focuses on introducing participants to the concept of anti-inflammatory diets and their potential benefits. The lecture will provide an overview of foods that have anti-inflammatory properties. The objective is to empower individuals with knowledge about dietary choices that can help reduce inflammation and support optimal health.

Objective #3: To provide practical information for implementing an anti-inflammatory diet/lifestyle. The objective is to enable participants to make informed dietary choices and embrace a long-term anti-inflammatory lifestyle.

Monica D. Shah, DO, Teaching Faculty, Rheumatology Fellowship Program Bayonet Point Hospital via HCA Healthcare Florida/University of South Florida Hudson, FL

Objective #1: Recognize the four classes of guideline-directed medical therapies indicated for patients with heart failure and be comfortable initiating and titrating them.

Objective #2: Identify patients who need to be referred to a heart failure and transplant cardiologist for consideration of advanced therapies such as heart transplants and left ventricular assist devices.

Objective #3: Understand that disparities exist across the spectrum of heart failure from prevention of heart failure to allocation of organs in heart transplantation.

Nasrien Ibrahim, MPH, MD, Advanced Heart Failure and Transplant Cardiologist

Objective #1: Defining Obesity from its clinical perspective

Objective #2: Appreciating the pathophysiology of Obesity in terms of Dysadiposity and its relevance to other chronic disease states.

Objective #3: Reviewing the Pharmacologic Treatment Strategies currently available for Dysadiposity

Eric S. Langer, DO, FACOI, Program Director, Endocrinology Fellowship Training Program

Objective #1: Understand lab testing in adrenal insufficiency diagnosis.

Objective #2: Understand adrenal biopsy contraindications.

Objective #3: Understanding Lab testing is Cushing Syndrome diagnosis.

John R. Sutton, DO, MACOI, American College of Osteopathic Internists, Past President

Objective #1: 1. Discuss the stages of Type 1 Diabetes Mellitus

Objective #2: 2. Review use of teplizumab-mzwv new medical therapy to delay the onset of Type 1 Diabetes Mellitus

Objective #3: 3. Discuss how technology can impact the management of Type 1 Diabetes Mellitus

Erica M. Kretchman, DO, Endocrinologist

1. Define and understand health disparities.

2. Understand who is impacted by health disparities.

3. Understand social determinants of health (SDOH) and their implications on patients, health care and the economy.

Kellee L. Randle, DO, FACOI (she/her/hers), Physician, CEO, Assistant Professor, UNT HSC Texas College of Osteopathic Medicine/Equity Ventures Plus, LLC,

Objective #1: Determine optimal use for Artificial Intelligence in Medicine

Objective #2: Understand problems with regulation and ethical use of AI collected information

Objective #3: Assess the cultural, moral and ethical deficiencies in the current collection techniques and work for patient's best interest

Deanah A. Jibril, DO, MS, MBA, Chief Medical Officer, Queenscare

Humera (Mena) Khan, MD, Medical Simulation Program Leader

1. Understand new science
2. Review of prior important trials
3. New translational data
4. Guidelines

Robert J. Chilton, DO, MACOI, Professor of Medicine, University of Texas Health Science Center

Objective #1: Define traditional vs. emerging risk factors for coronary artery disease.

Objective #2: Discuss emerging imaging techniques for the detection and prevention of coronary artery disease.

Objective #3: Discuss various patient case studies and how differing imaging and laboratory studies changed their respective treatment strategies.

Tiffany S. DiPietro, DO, FACOI, Associate Clinical Professor Kiran C Patel College of Osteopathic Medicine Fort Lauderdale, Florida

Objective #1: To review the current clinical trials in patients with congestive heart failure and the role of a structured exercise program

Objective #2: Discuss recommendations for a structured exercise program in patients with congestive heart failure?

Objective #3: Review the key medical conditions that contribute to the development of congestive heart failure and how exercise plays a role in these conditions.

Chad A. Link, DO, FACC, FACOI, Cardiologist, University of Michigan Health- Sparrow

•Gain confidence and skills in your approach to the Goals of Care conversation.

•Be able to use the Dialectic conversation in your interaction with seriously ill patients.

•Learn to avoid words or phrases that stop the patient and family acceptance of your supportive conversation.

•The Goals of Care is about quality decisions.

Leonard R. Hock, DO, MACOI, Consultant in Palliative Medicine, Consultant in Palliative Medicine

Objective #1:

The discuss the treatment of patients with heart failure with reduced left ventricular function (HFrEF) and review the four pillars of therapy recommended by the Heart Failure Society of America (HFSA)/ACC.

Objective #2:
To review the current recommendations for treating patients with heart failure with preserved left ventricular function and to review the current clinical trials

Objective #3:
To review the pathophysiology of patients presenting with congestive heart failure and appropriate diagnostic and treatment recommendations.

Chad A. Link, DO, FACC, FACOI, Cardiologist, University of Michigan Health- Sparrow

Objective #1: Gain a deeper understanding of pathophysiology of chronic rhinitis.

Objective #2: Gain an understanding of the many types of chronic rhinitis

Objective #3: Discuss the many types of nasal sprays and when the best time is to use each one.

John A. Frith, DO, FAAAAI, Allergy/Immunology Physician, Michigan State College of Osteopathic Medicine

Objective #1: Briefly review the diagnosis of asthma including information about asthma phenotypes

Objective #2: Review information about the current Global Initiative for Asthma (GINA) for short including July 2023 update

Objective #3: Discuss current treatment options related to biologic medications

Julie Sterbank, DO, FACOI, Associate Professor, Internal Medicine & Pediatrics; Adult and Pediatric, Allergy & Immunology, Case Western University/MetroHealth Medical Center

Objective #1: At the end of this lecture, the participant will be able to identify the signs, symptoms, and stages of syphilis.

Objective #2: At the end of this lecture, the participant will be able to recognize and interpret the various laboratory tests used in the diagnosis of syphilis.

Objective #3: At the end of this lecture, the participant will be able to understand and implement the current treatment recommendations for all stages of syphilis.

Andrea Sciberras, DO, FACOI, Medical Director, Division of Disease Control and Health Protection, Florida Department of Health

Session details coming soon.

Patrick J. Kenney, DO, FACOI, Vice Chair, Department of Infectious Disease, Cleveland Clinic Florida

Objective #1: To review and discuss latest guidelines regarding COVID and seasonal influenza vaccinations

Objective #2: To review updated vaccination guidelines for routine adult vaccines

Objective #3: To discuss additional vaccine recommendations for certain higher risk travel abroad

Mia A. Taormina, DO, FACOI, Chair, Department of Infectious Disease, Duly Health and Care

Session details coming soon.

MarkAlain Déry, DO, MPH, FACOI (he/him/his), Chief Innovation Officer, Access Health Louisiana

Objective #1: Learn what a biologic medication is

Objective #2: Know the difference between a biologic medication, biosimilar medication, and interchangeable biosimilar medication

Objective #3: Know the types of side effects which can occur with biologic and biosimilar medications

Howard L. Feinberg, DO, MACOI, Associate Dean

Objective #1: Review the current state initiatives of Medical Marijuana Legalization (MML) and Recreational Marijuana Legalization and its economic impact in the US

Objective #2: Assess the current Evidence-based Research of Cannabinoid compounds

Objective #3: Discuss Cannabis Use Disorder as an "underappreciated risk of using cannabis"

C. Clark Milton, DO, FACOI, Assistant Professor of Internal Medicine

Objective #1: Define palliative care in the context of cancer, citing the World Health Organization's official definition.

Objective #2: Discuss the importance of early integration of palliative care in patients with advanced cancer diagnoses

Objective #3: Examine the guidelines and recommendations for integrating palliative care into standard oncology care, as presented by the American Society of Clinical Oncology and the National Comprehensive Cancer Network.

Jason R. Beckrow, DO, FACOI, FAAHPM, HMDC (he/him/his), Assistant Professor

1. Discuss 2 skills in building a foundation of trust with patients by increasing our listening skills.

2. Identify 2 risk factors in preventing a crisis through whole patient centered care.

3. Identify 3 tools that aid in care giver support.

Sandra P. Gomez, MD, Sage Health Medical Director Provider Training and Care Model Innovation

Objective #1: To understand what the responsibilities physician have with regard to their colleagues being impaired.

Objective #2: Lay out generally accepted practice in the approach to suspected impairment of physicians in the clinical setting.

Objective #3: Clearly delineate the rights of the physician suspected of impairment and the process of aiding them into recovery.

Thomas F. Jan, DO, Founding and Current Chair American Osteopathic Pain Medicine Conjoint Examination Committee

Session details coming soon.

Dominic F. Glorioso, Jr., DO, PhD, FACOI, FAAHPM, HMD (he/him/his), Associate Medical Director, Amedisys Hospice

Thomas F. Jan, DO, Founding and Current Chair American Osteopathic Pain Medicine Conjoint Examination Committee

Objective #1: Discuss criteria for the diagnosis and staging of Chronic Kidney Disease (CKD) and Examine real-world practices for CKD screening and monitoring.

Objective #2: Review the current recommendations for the assessment of kidney function.

Objective #3: Describe methods for prognostication in both early and advanced CKD.

Tarra Faulk, DO, Assistant Professor of Medicine Uniformed Services University of the Health Sciences F. Edward Hébert School of Medicine Bethesda, Maryland

Objective #1: Understand the mechanism of action of thiazide diuretics

Objective #2: Determine if there is sufficient evidence supporting the continued use of thiazide diuretics for reducing risk of calcium oxalate stone formation

Objective #3: Appreciate the current clinical scenarios where use of thiazide diuretics should be considered

David S. Levy, DO, FACOI, FASN (he/him/his), Assistant Professor of Clinical Medicine

Session details coming soon.

Objective #1: Highlight when to raise awareness for that a glomerular disease may be present

Objective #2: Discuss the epidemiology, prognostic factors and pathogenesis of IgA Nephropathy

Objective #3: Review treatment recommendations for IgA Nephrology given contemporary findings

Laura S. Maursetter, DO, Associate Professor of Nephrology

Objective #1: To understand the Treatment as Prevention

Objective #2: To understand Post-Exposure Prophylaxis

Objective #3: To Understand Pre-Exposure Prophylaxis

Erik D. Wert, DO, FACOI